Shareholders Equity: The sum of preferred and common equity items.
Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) had Shareholders Equity of $11.73M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$3.49M |
|
$10.71M |
|
$13.69M |
|
$17.18M |
|
$2.23M |
|
$0.28M |
|
$3.21M |
|
$5.44M |
|
$6.11M |
|
$11.73M |
|
|
Shareholders Equity |
$11.73M |
5.70M |
|
| Cash Flow Statement Financials | |
$-3.92M |
|
$2.64M |
|
$2.33M |
|
$1.81M |
|
$2.85M |
|
$1.04M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|